#1 Clinical Trials Search in Europe

DROSPIRENONE

Drospirenone is a synthetic progestin used in various hormonal medications, particularly for contraception and treating hormone-related conditions. This article explores how drospirenone is being studied in clinical trials, both alone and in combination with other hormones such as ethinyl estradiol or estetrol. These trials investigate drospirenone’s effectiveness for contraception, its effects on conditions like endometriosis and polycystic ovary syndrome (PCOS), and its impact on bone health, cardiovascular function, and other health parameters. By examining current research, we can better understand the potential benefits and considerations of medications containing drospirenone.

Table of Contents

What is Drospirenone?

Drospirenone is a synthetic progestin (a type of hormone similar to the naturally occurring hormone progesterone) used in various contraceptive formulations and hormonal treatments. What makes drospirenone unique among progestins is that it has properties similar to natural progesterone and is also a potent inhibitor of mineralocorticoid activity (meaning it can affect how your body manages salt and water) [1]. This gives drospirenone some distinct advantages in treating certain conditions.

Drospirenone is commonly found in birth control pills, but it’s also being studied and used as a standalone medication. It has several medical applications beyond contraception, including treatment of endometriosis, polycystic ovary syndrome (PCOS), acne, and premenstrual symptoms.

Medical Uses

Clinical trials have shown that drospirenone can be effective for several medical conditions:

  • Contraception (birth control)
  • Treatment of endometriosis and adenomyosis
  • Management of PCOS (Polycystic Ovary Syndrome)
  • Treatment of acne
  • Relief of premenstrual symptoms
  • Hormone replacement therapy (when combined with estradiol)

Drospirenone for Contraception

Drospirenone is widely used in oral contraceptives, both in combination with estrogens and as a progestin-only pill. Several clinical trials have demonstrated its effectiveness as a contraceptive [2].

Drospirenone-only pills typically contain 4 mg of drospirenone and are taken once daily. These are sometimes called “mini-pills” and are an option for women who cannot or choose not to take estrogen-containing contraceptives [3]. Research indicates that drospirenone effectively inhibits ovulation when taken daily, making it an effective birth control method.

Combined oral contraceptives containing drospirenone typically include drospirenone (3 mg) along with ethinyl estradiol (0.02-0.03 mg) or estetrol (15 mg). These are usually taken in a 24/4 regimen (24 days of active hormone tablets followed by 4 days of inactive tablets or low-dose tablets) [4].

Drospirenone-containing contraceptives work by:

  • Inhibiting ovulation (preventing the release of an egg from the ovary)
  • Thickening cervical mucus to prevent sperm from reaching the egg
  • Thinning the uterine lining, making it less receptive to implantation

Studies are also investigating the potential use of drospirenone for emergency contraception. One clinical trial is exploring whether a single high dose of drospirenone could effectively prevent pregnancy after unprotected intercourse [5]. This could potentially provide an additional option for emergency contraception, particularly for women with higher BMI for whom current options may be less effective.

Drospirenone for Endometriosis and Adenomyosis

Endometriosis is a chronic condition where tissue similar to the uterine lining grows outside the uterus, causing pain and potentially infertility. Adenomyosis is a related condition where the endometrial tissue grows into the muscle wall of the uterus.

Clinical trials have shown that drospirenone may be effective in treating these conditions [6]. One study is investigating the use of drospirenone (4 mg daily) for 20 weeks to treat adenomyosis, with the primary goal of reducing chronic pain associated with the condition [1].

When combined with estetrol (a naturally occurring estrogen), drospirenone has been shown to reduce the size of ovarian endometriomas (also called “chocolate cysts”) [6]. This combination is being studied for its ability to:

  • Reduce the size of endometriomas
  • Relieve pain associated with endometriosis
  • Prevent recurrence of endometriosis after surgery
  • Lower levels of CA125 (a blood marker often elevated in endometriosis)

For women with endometriosis-associated pelvic pain, drospirenone has shown promise in clinical trials. It works by reducing the proliferation of endometrial tissue and decreasing the expression of Ki-67 (a marker of cell proliferation) in the endometrium [7].

Drospirenone for PCOS

Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting women of reproductive age. It’s characterized by irregular periods, excess androgen levels (male hormones), and polycystic ovaries. PCOS often presents with symptoms like hirsutism (excess hair growth), acne, and sometimes obesity and insulin resistance.

Drospirenone, particularly when combined with ethinyl estradiol, has been used to treat PCOS [8]. This combination works by:

  • Reducing androgen levels, which helps with symptoms like excess hair growth and acne
  • Regulating menstrual cycles
  • Protecting the uterine lining from abnormal growth

One notable property of drospirenone is its anti-androgenic effect, which means it counteracts male hormones in the body. This makes it particularly useful for PCOS patients who often have elevated androgen levels [9].

A clinical trial is currently exploring whether drospirenone can be used to prevent LH (luteinizing hormone) surge in PCOS cases undergoing assisted reproductive technology (ART) cycles [10]. LH surge in PCOS can lead to premature ovulation or ovarian hyperstimulation syndrome during fertility treatments, so controlling it could improve outcomes.

Drospirenone for Acne

Acne is a common skin condition that can be influenced by hormonal factors. Due to its anti-androgenic properties, drospirenone-containing contraceptives have been shown to be effective in treating moderate acne [11].

A large clinical trial evaluated the efficacy of YAZ (drospirenone 3 mg / ethinyl estradiol 20 μg) for treating moderate acne over 6 treatment cycles. The study found that this formulation significantly reduced total acne lesion count compared to placebo [11].

Drospirenone helps with acne by:

  • Reducing the production of sebum (skin oil) by blocking androgen effects on sebaceous glands
  • Decreasing inflammation associated with acne
  • Regulating hormonal fluctuations that can trigger acne breakouts

Drospirenone for Premenstrual Syndrome

Premenstrual syndrome (PMS) and its more severe form, premenstrual dysphoric disorder (PMDD), can cause significant physical and emotional symptoms before menstruation. Drospirenone has unique properties that make it effective for managing these symptoms [12].

Unlike other progestins, drospirenone has antimineralocorticoid activity, which means it helps the body eliminate excess water. This can reduce bloating and fluid retention commonly experienced during PMS. Its antiandrogenic properties may also help with premenstrual acne flare-ups.

A clinical trial investigated the use of drospirenone/ethinyl estradiol for premenstrual worsening of depression, showing that it can help stabilize mood fluctuations associated with the menstrual cycle [12].

Cardiovascular Effects

Drospirenone’s impact on the cardiovascular system is being studied in clinical trials. One study is evaluating the effect of different hormonal contraceptives, including drospirenone-only pills and combinations with estrogens, on 24-hour blood pressure in cycling women [13].

The antimineralocorticoid activity of drospirenone may offer advantages for certain women, particularly those with tendency toward fluid retention or slightly elevated blood pressure. However, it’s important to note that like other hormonal contraceptives, drospirenone-containing products may increase the risk of blood clots in some women, particularly those with other risk factors [14].

Another study examined the effects of combined estradiol and drospirenone treatment versus combined estradiol and medroxyprogesterone acetate treatment on endothelial function (the function of the cells lining blood vessels) [15]. This research helps to understand how different hormone combinations might affect cardiovascular health.

Effects on Bone Health

The impact of hormonal contraceptives on bone health is an important consideration, particularly for younger women who are still developing bone mass and for long-term users. Clinical trials are investigating the effects of drospirenone on bone mineral density (BMD) [16].

One ongoing study is comparing the effects of drospirenone-containing contraceptives with non-hormonal contraceptive methods on BMD in both adolescent and adult women [16]. This research will help determine whether drospirenone has any significant impact on bone development or maintenance.

For adolescents in particular, understanding the effects of hormonal contraceptives on bone health is crucial, as these are years when peak bone mass is being established.

Different Formulations

Drospirenone is available in several different formulations:

  • Drospirenone-only pills: Typically containing 4 mg of drospirenone, taken daily [3]
  • Combined with ethinyl estradiol: Common formulations include 3 mg drospirenone with either 0.02 mg or 0.03 mg ethinyl estradiol [17]
  • Combined with estetrol: A newer formulation containing 3 mg drospirenone with 15 mg estetrol [13]
  • Combined with estradiol: Used primarily for hormone replacement therapy in menopausal women [14]
  • Chewable tablets: A newer formulation of drospirenone that can be chewed rather than swallowed whole [16]

The choice of formulation depends on the specific medical needs of the patient, potential side effects, and personal preferences. For example, women who cannot take estrogen might opt for a drospirenone-only pill, while those with PCOS might benefit from a combined formulation with ethinyl estradiol.

Side Effects and Safety

Like all medications, drospirenone can cause side effects. Common side effects may include:

  • Headache
  • Nausea
  • Breast tenderness
  • Mood changes
  • Irregular bleeding or spotting, especially during the first few months
  • Changes in weight

Due to its antimineralocorticoid properties, drospirenone can increase potassium levels in some people. This is generally not a problem for healthy individuals, but may be a concern for those with kidney, liver, or adrenal disease, or for those taking medications that can also increase potassium levels [18].

As with other hormonal contraceptives, there is a slightly increased risk of blood clots, particularly in women with other risk factors such as smoking, obesity, or a personal or family history of clotting disorders. However, the overall risk is still low for most women [4].

Clinical trials continue to monitor the safety of drospirenone in various populations and formulations, with many studies including specific safety outcomes to better understand its risk profile [5].

Special Considerations

Certain groups of patients may need special consideration when using drospirenone:

Women with obesity: Studies are investigating the pharmacokinetics (how the drug moves through the body) of drospirenone in obese women, including before and after bariatric surgery [3]. This research will help determine whether dosage adjustments might be needed for women with higher body weight.

Adolescents: The effect of drospirenone on bone mineral density in adolescents is being studied, as this is an important period for bone development [16].

Women with kidney or liver problems: Due to drospirenone’s effect on potassium levels, women with impaired kidney or liver function may need careful monitoring when using this medication [13].

Women taking other medications: Drospirenone can interact with certain medications, particularly those that also affect potassium levels. Always inform your healthcare provider about all medications you’re taking [19].

In conclusion, drospirenone is a versatile hormone medication used in various formulations for contraception and to treat several conditions including PCOS, endometriosis, acne, and premenstrual symptoms. Its unique properties make it particularly useful for certain groups of women, though like all medications, it comes with potential side effects and considerations. Always discuss with your healthcare provider to determine if a drospirenone-containing product is right for you.

Application Formulations Key Findings from Clinical Trials
Contraception – Drospirenone-only pills (4 mg)
– Drospirenone + ethinyl estradiol
– Drospirenone + estetrol 		– Effective for pregnancy prevention
– Drospirenone-only formulations being studied for women who can’t use estrogen
– Studies examining efficacy across different BMI categories
– Research on absorption after bariatric surgery
Endometriosis & Endometriomas – Drospirenone + estetrol
– Drospirenone + ethinyl estradiol 		– May reduce endometrioma size after 3-6 months of treatment
– Shows potential for pain reduction
– Being compared with other hormonal treatments
PCOS Management – Drospirenone + ethinyl estradiol
– Combined with metformin in some studies 		– Helps manage hyperandrogenism symptoms
– May improve insulin sensitivity when combined with metformin
– Some studies show improvements in endothelial function
Acne Treatment – Drospirenone + ethinyl estradiol (YAZ) – Significant reduction in total acne lesion count
– Improvements in both inflammatory and non-inflammatory lesions
– Anti-androgenic properties beneficial for hormonal acne
Cardiovascular Effects – Various drospirenone formulations
– Studied alone and in combination 		– Anti-mineralocorticoid effects may benefit blood pressure
– Studies examining 24-hour blood pressure patterns
– Research on endothelial function and cardiovascular markers
Bone Health – Drospirenone alone
– Drospirenone + ethinyl estradiol 		– Studies examining effects on bone mineral density, especially in adolescents
– Research tracking changes in bone turnover markers
– Long-term monitoring for potential impacts on bone health
Emerging Applications – Various formulations – Potential use as emergency contraception
– Management of adenomyosis-associated pain
– Premenstrual mood disorder treatment
– Endometrial preparation before procedures

FAQ

  • What is drospirenone and how does it work? Drospirenone is a synthetic progestin (a form of progesterone) used in oral contraceptives and hormone replacement therapy. It works by preventing ovulation, thickening cervical mucus to prevent sperm from reaching an egg, and changing the uterine lining to prevent implantation of a fertilized egg. Drospirenone is unique among progestins because it also has anti-mineralocorticoid properties (similar to the diuretic spironolactone) and anti-androgenic effects, which can help reduce water retention and may benefit skin conditions like acne.
  • What conditions is drospirenone being studied for in clinical trials? Clinical trials are investigating drospirenone for multiple uses including: contraception (both combined with estrogens and as drospirenone-only pills), treatment of endometriosis and endometriomas (chocolate cysts), management of PCOS (polycystic ovary syndrome), treatment of adenomyosis, premenstrual syndrome relief, acne treatment, blood pressure effects, and as a potential emergency contraceptive. Some studies are also examining its effects on bone mineral density and cardiovascular health.
  • How effective is drospirenone for contraception? Studies show that drospirenone is highly effective for contraception, whether used alone or in combination with estrogens like ethinyl estradiol or estetrol. Drospirenone-only pills (4mg daily) are being studied for their contraceptive efficacy, with research measuring parameters like the Pearl Index (number of pregnancies per 100 woman-years). The effectiveness appears comparable to other hormonal contraceptives, with the benefit of potentially fewer side effects for some users. Clinical trials are also examining how factors like body weight and bariatric surgery might affect drospirenone's absorption and effectiveness.
  • What are the potential side effects or risks of drospirenone-containing medications? Common side effects of drospirenone-containing medications may include irregular bleeding, headache, nausea, breast tenderness, and mood changes. Because of drospirenone's effect on potassium levels, some studies monitor serum potassium as a safety outcome. Clinical trials are investigating cardiovascular effects, including blood pressure changes, since drospirenone has anti-mineralocorticoid properties that may affect fluid balance. Some studies are also examining the drug's impact on bone mineral density, particularly in adolescents, to ensure long-term safety. As with all hormonal medications, the benefits and risks should be weighed individually with healthcare providers.
  • How is drospirenone being studied for conditions besides contraception? Beyond contraception, drospirenone is being studied for various conditions including: treatment of endometriosis and endometriomas (with studies showing it may reduce cyst size and pain), management of PCOS symptoms (potentially improving insulin sensitivity when combined with other treatments), treatment of adenomyosis (to reduce pelvic pain), premenstrual depression, and acne (with research showing improvement in inflammatory and non-inflammatory acne lesions). Some studies are also investigating its effects on cardiovascular markers, blood pressure, and endothelial function. Researchers are particularly interested in drospirenone's unique properties compared to other progestins.

Ongoing Clinical Trials on DROSPIRENONE

  • A study comparing the effects of estetrol and drospirenone, ethinylestradiol and drospirenone, and drospirenone in women with polycystic ovary syndrome (PCOS)

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Finland

  • Contraception study in women: comparing oral drospirenone‑only, drospirenone + ethinylestradiol, and drospirenone + estetrol tablets

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Finland

  • Study on the Impact of LF111 and Drospirenone on Bone Health in Adolescent and Adult Women Using Oral Contraceptives

    Not recruiting

    1 1 1
    Investigated drugs:
    Czechia Poland

  • Study on the Effects of Hormonal Contraceptives on the Brain: Comparing Drospirenone and Estetrol with Ethinylestradiol and Levonorgestrel in Women Using Contraception

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Sweden

Glossary

  • Drospirenone: A synthetic progestin used in hormonal contraceptives that has anti-mineralocorticoid and anti-androgenic properties. It works by preventing ovulation, thickening cervical mucus, and changing the uterine lining.
  • Ethinyl Estradiol: A synthetic form of estrogen commonly used in combination with progestins like drospirenone in oral contraceptives. It helps maintain the uterine lining and works with progestins to prevent pregnancy.
  • Estetrol: A naturally occurring estrogen that is being used in newer contraceptive formulations with drospirenone. It may have a more selective action and potentially improved safety profile compared to other synthetic estrogens.
  • Pearl Index: A measurement used to assess contraceptive effectiveness, calculated as the number of pregnancies per 100 woman-years of exposure. Lower numbers indicate better effectiveness.
  • PCOS (Polycystic Ovary Syndrome): A hormonal disorder causing enlarged ovaries with small cysts, irregular periods, excess androgen levels, and often insulin resistance. Drospirenone may help manage symptoms due to its anti-androgenic properties.
  • Endometriosis: A condition where tissue similar to the uterine lining grows outside the uterus, causing pain and sometimes infertility. Studies are examining drospirenone's effectiveness in managing symptoms.
  • Endometrioma: A type of cyst formed when endometrial tissue grows in the ovaries, also called 'chocolate cysts.' Clinical trials are studying whether drospirenone can reduce their size.
  • Adenomyosis: A condition where the endometrial tissue grows into the muscular wall of the uterus, causing painful, heavy periods. Research is investigating drospirenone's effect on reducing associated pain.
  • Bone Mineral Density (BMD): A measurement of the amount of minerals (primarily calcium) in bones, which indicates bone strength. Some clinical trials examine drospirenone's long-term effects on BMD, especially in adolescents.
  • Flow-Mediated Dilation (FMD): A non-invasive method to assess endothelial function and overall cardiovascular health by measuring how blood vessels dilate in response to increased blood flow.
  • Ambulatory Blood Pressure Monitoring (ABPM): A method to measure blood pressure at regular intervals over 24 hours during normal daily activities and sleep. Used in clinical trials to assess drospirenone's effects on blood pressure.
  • Pharmacokinetics: The study of how drugs move through the body, including absorption, distribution, metabolism, and excretion. Several trials study drospirenone's pharmacokinetics in different populations.
  • Modified Insler Score: A scoring system used to evaluate cervical mucus characteristics (including ferning, spinnbarkeit, viscosity, and cellularity) to assess fertility status and ovulation.
  • Hyperandrogenism: A medical condition characterized by excessive production of male hormones (androgens) in females, causing symptoms like acne, excessive hair growth, and irregular periods.
  • Insulin Resistance: A condition where cells don't respond properly to insulin, leading to higher blood sugar levels. Often associated with PCOS, and some studies examine drospirenone's effects on insulin sensitivity.
  • Drug-Drug Interaction: When one medication affects how another medication works, potentially changing effectiveness or side effects. Several studies examine how drospirenone interacts with other medications.
  • Dual-Energy X-ray Absorptiometry (DXA): A technology used to measure bone mineral density and body composition using low-dose X-rays. Used in clinical trials to assess drospirenone's effects on bone health.
  • Bariatric Surgery: Weight loss surgery that changes how the digestive system works. Some trials examine how this surgery affects the absorption and effectiveness of drospirenone.

References

  1. https://clinicaltrials.gov/study/NCT06174792
  2. https://clinicaltrials.gov/study/NCT02269241
  3. https://clinicaltrials.gov/study/NCT06345560
  4. https://clinicaltrials.gov/study/NCT05461573
  5. https://clinicaltrials.gov/study/NCT05675644
  6. https://clinicaltrials.gov/study/NCT05837624
  7. https://clinicaltrials.gov/study/NCT05156879
  8. https://clinicaltrials.gov/study/NCT01459445
  9. https://clinicaltrials.gov/study/NCT01511822
  10. https://clinicaltrials.gov/study/NCT06608186
  11. https://clinicaltrials.gov/study/NCT00818519
  12. https://clinicaltrials.gov/study/NCT00633360
  13. https://clinicaltrials.gov/study/NCT07061093
  14. https://clinicaltrials.gov/study/NCT00102141
  15. https://clinicaltrials.gov/study/NCT01109979
  16. https://clinicaltrials.eu/trial/study-on-the-impact-of-lf111-and-drospirenone-on-bone-health-in-adolescent-and-adult-women-using-oral-contraceptives/
  17. https://clinicaltrials.gov/study/NCT06233058
  18. https://clinicaltrials.gov/study/NCT05706753
  19. https://clinicaltrials.gov/study/NCT05985590